Interventions for disorders of eye movement in patients with stroke
| Autor: | Frank A. Munro, Katrina Livingstone, Uma Shahani, Baljean Dhillon, Alex Pollock, Fiona J. Rowe, Christine Hazelton, Heather Orr, Jayne Angilley, Clair A. Henderson, Peter Langhorne |
|---|---|
| Rok vydání: | 2011 |
| Předmět: |
Adult
medicine.medical_specialty Blinding Activities of daily living genetic structures Psychological intervention Muscarinic Antagonists Cochrane Library Physical medicine and rehabilitation Ocular Motility Disorders Activities of Daily Living Medicine Humans Pharmacology (medical) Functional ability Stroke Randomized Controlled Trials as Topic business.industry Eye movement medicine.disease Trihexyphenidyl Physical therapy Anxiety medicine.symptom business |
| Zdroj: | Scopus-Elsevier Cochrane Database of Systematic Reviews The Cochrane Library |
| ISSN: | 1469-493X |
| Popis: | Background Eye movement disorders may affect over 70% of stroke patients. These eye movement disorders can result in difficulty maintaining the normal ocular position and difficulty moving the eyes appropriately. The resulting functional disabilities include a loss of depth perception, reduced hand-to-eye co-ordination, marked difficulties with near tasks and reading and reduced ability to scan the visual environment. They can also impact on the effectiveness of rehabilitation therapy. There are a wide variety of different treatment interventions proposed for eye movement disorders after stroke. However, in the past, there has been a lack of evidence specific to the impact of interventions on the functional outcome of patients with stroke. Objectives To determine the effects of interventions for eye movement disorders on functional ability following stroke. Search methods We searched the Cochrane Stroke Group Trials Register (February 2011), the Cochrane Eyes and Vision Group Trials Register (December 2009) and nine electronic bibliographic databases including CENTRAL (The Cochrane Library 2009, Issue 4), MEDLINE (1950 to December 2009), EMBASE (1980 to December 2009), CINAHL (1982 to December 2009), AMED (1985 to December 2009), and PsycINFO (1967 to December 2009). We also searched reference lists and trials registers, handsearched journals and conference proceedings, and contacted experts. Selection criteria Randomised trials in adults after stroke where the intervention was specifically targeted at improving the eye movement disorder or improving the ability of the participant to cope with the eye movement disorder. The primary outcome was functional ability in activities of daily living. Secondary outcomes included functional ability in extended activities of daily living, eye movement measures, balance, falls, depression or anxiety, discharge destination or residence after stroke, quality of life and social isolation, adverse events, and death. Data collection and analysis Two authors independently screened abstracts, extracted data and appraised trials. We undertook assessment of methodological quality for allocation concealment, blinding of outcome assessor, method of dealing with missing data, and other potential sources of bias. Main results Two studies (28 participants but only five were people with stroke) met the inclusion criteria and were included in this review. Both studies investigated pharmacological interventions for disorders of eye movement in patients with stroke. It was not appropriate to pool data and we were not able to draw conclusions from these studies. We found no other randomised studies which investigated interventions for disorders of eye movement in patients with stroke. Authors' conclusions There is insufficient evidence to reach conclusions about the effectiveness of interventions for patients with eye movement disorders after stroke. High quality research in the form of well-designed randomised trials are urgently required. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|